Clinical Trial: Oncology - MiRNA

Overview

MiRNA

A Pilot Study: "Analysis of Serum miRNA from Women Referred for Breast Biopsy with Abnormal Breast Imaging Classified as BI-RADS 4 or 5"

Objective

By drawing a tube of blood, data is obtained that will hopefully improve the breast cancer screening process in the future. Researchers are looking at serum miRNA signatures to determine if a subsequent breast biopsy has a higher likelihood of being positive or negative. This study is recruiting patients have breast imaging studies suspicious for cancer discovered during screening.

Principal Investigator(s)

Steven Scallon, MD, Radiologist, Breast Health

Study Contact(s)

Stephanie Porenta, RN BSN CCRC: 425.467.3986, Stephanie.Porenta@overlakehospital.org  

Pooja Rajeevan, CRC: 425.635.6081, Pooja.Rajeevan@overlakehospital.org

Clinical Trial Categories 

Oncology